FdaApplication
ANDA 217731
Identifiers
- fda_app_no: ANDA217731
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2023-08-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE/5ML | SOLUTION;ORAL |
1 product